1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FGF19 CTRPv2 pan-cancer AAC 0.1 0.0007
mRNA CHKB-CPT1B CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA MFSD5 CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA EML5 CTRPv2 pan-cancer AAC 0.14 0.0007
mRNA HSPA5 CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA NLGN3 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA SPRYD7 CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA FBXO11 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA TLE2 CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA GPRC5D CTRPv2 pan-cancer AAC -0.1 0.0007
Download CSV